Centre de Lutte Contre le Cancer (CLCC) - Institut Bergonie

Bordeaux, Other 33000

0 studies enrolling now · 1 studies all time

What they study most

Diffuse Large B-cell Lymphoma

Studies at this site

• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling